Hemo Organic Limited

Hemo Organic Limited

BBSE:HEMORGANIC
22.97
INR
0.00
(0.00%)
-2.21EPS
74.59MMarket Cap
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
2026 Y
TTM
Revenue per Share
2.09
0.47
0.33
1.73
0.23
0.16
0.76
0.02
0.02
0.01
0.06
6.97
2.68
2.67
Basic EPS, GAAP
0.11
-0.31
-2.42
-0.23
-0.4
-0.35
-0.06
-0.14
-0.18
-0.16
-0.76
0.47
-2.25
-2.21
Free Cash Flow per Basic Share
0.19
0.19
-2.3
-0.44
-0.33
-0.12
0.02
-0.04
-0.01
0.31
-3.43
-1.04
-4.21
- -
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
4.23
3.54
1.2
1.16
0.74
0.39
0.33
0.19
0.01
-0.15
-0.91
-0.44
0.38
- -
Tangible Book Value per Share
4.23
3.54
1.2
1.16
0.74
0.39
0.33
0.19
0.01
-0.15
-0.91
-0.44
0.38
- -
Basic Weighted Avg Shares
3
3
3
3
4
3
4
3
3
3
3
3
3
3
Sales/Revenue/Turnover
7
2
1
6
1
1
3
- -
- -
- -
- -
24
9
9
Operating Margin (%)
-24.31
-81.4
-104.9
-13.14
-116.51
-152.31
-2.06
-591.47
-910.67
-1,135.42
-1,088.39
-2.06
-53.46
-49.62
Depreciation Expense
1
1
1
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Net Income, GAAP
- -
-1
-8
-1
-1
-1
- -
- -
-1
-1
-3
2
-8
-8
Effective Tax Rate (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Profit Margin (%)
5.1
-66.68
-741.48
-13.14
-170.34
-219.71
-7.87
-593.22
-913.15
-1,137.5
-1,179.02
6.79
-83.76
-82.69
Working Capital
2
1
2
3
2
1
- -
- -
-1
-2
8
10
29
- -
LT Debt
- -
- -
- -
- -
1
1
- -
- -
- -
- -
12
15
27
- -
Total Equity
15
12
4
4
3
1
1
1
- -
-1
-3
-2
1
- -
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Common Equity (%)
2.48
-7.77
-99.33
-19.17
-44.9
-61.38
-17.52
-53.35
-180.19
- -
- -
- -
- -
- -

Capital Structure

INR

•

in mil. unless spec.
Dec'26
Mar'26
Jun'27
ST Debt
- -
- -
- -
LT Borrowings
- -
27
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
3
3
4
Market Capitalization
59
41
75

Working Capital

INR

•

in mil. unless spec.
Dec'26
Mar'26
Jun'27
Total Current Assets
- -
45
- -
Cash, Cash Equivalents & STI
- -
- -
- -
Accounts Receivable, Net
- -
24
- -
Inventories
- -
5
- -
Total Current Liabilities
- -
16
- -
Payables & Accruals
- -
- -
- -
ST Debt
- -
- -
- -
Deferred Revenue
- -
- -
- -

Growth Rates

INR

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
-155.89%
-282.76%
-187.72%
Free Cash Flow
-417.45%
-712.71%
303.54%
Net Income, GAAP
-31.89%
-67.06%
-574.74%
Sales/Revenue/Turnover
1,156.52%
2,187.64%
-61.52%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
- -
- -
- -
24
24
2026
- -
- -
- -
9
9
2027
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
-0.01
-0.23
-0.23
1.08
0.47
2026
-0.25
-0.09
-0.45
-1.46
-2.25
2027
-0.21
- -
- -
- -
- -

Quarterly Dividends Per Share

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -
2027
- -
- -
- -
- -
- -

Company Description

Sector
Process industries
Industry
Chemicals: specialty
Address
Ahmedabad India
IPO Date
May 30, 1994
Business
Hemo Organic Limited is an India-based trading and distribution enterprise primarily engaged in the procurement, supply, import, export, and marketing of agricultural commodities, biomass fuels, and healthcare products. The company's core product portfolio comprises agricultural food grains and cereals, including wheat, rice, and maize; fresh vegetables, including capsicums, tomatoes, green chilies, potatoes, cucumbers, and onions; fresh fruits, including apples, red dragon fruits, sweet limes, and pomegranates; renewable biomass fuels, including bio coal briquettes; and select pharmaceutical and dietary formulations, including medicinal tablets, rabeprazole domperidone capsules, and lycopene syrups. Operating primarily across Indian domestic agricultural and commercial supply networks, the company caters to wholesale distributors, commercial traders, and regional food aggregators. Founded in 1992 under the original name Dinesh Allorga Limited, Hemo Organic Limited is headquartered in Ahmedabad, Gujarat, India, and trades on the BSE under the ticker symbol HEMORGANIC. In recent strategic and operational developments, the company has completed a structural business transition from legacy chemical manufacturing toward agro-commodity trading, authorized capital-raising measures involving convertible warrants and equity instruments to reinforce liquidity and expand trading capacity, and implemented governance transitions, including the appointment of new statutory auditors at its thirty-fourth Annual General Meeting alongside restructuring within its corporate secretarial and executive compliance leadership.